Grupo Medinfar
Is this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Grupo Medinfar is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Neurology
Quick Facts
HQ:Portugal
Founded:2009
Employees:3,053
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval 03BZNW
Health Canada · #APR-VHWA9KU3 · 2021-07-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-RKN29CXS
Issued: 2020-02-19
Expires: 2025-01-18
WHO GMP
World Health Organization
Cert #: CERT-84OG9VG5
Issued: 2020-04-07
Expires: 2025-10-24
Health Canada GMP
Health Canada
Cert #: CERT-4HIAKTSK
Issued: 2020-10-14
Expires: 2025-08-14
Loading CDMO intelligence...
Key facts about Grupo Medinfar
- Grupo Medinfar is headquartered in Portugal.
- Grupo Medinfar was founded in 2009.
- Grupo Medinfar has 3,053 employees.
- Grupo Medinfar's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Grupo Medinfar
Directory pages this company appears in, each with the full list of matching manufacturers.